日水製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|---|---|---|
東証PRM | 医薬品 | 4550/E00971 | Nissui Pharmaceutical Co., Ltd |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|---|---|---|---|---|---|---|---|---|
2018/01/26 | 日証協 | 58,500株 | +5.22% | 5,000株 | -76.53% | 145,371株 | +0.83% | 10,108株 | +288.77% |
2018/01/19 | 日証協 | 55,600株 | +4.32% | 21,300株 | +82.05% | 144,168株 | +1.34% | 2,600株 | -43.48% |
2018/01/12 | 日証協 | 53,300株 | +1.33% | 11,700株 | +234.29% | 142,258株 | -13.97% | 4,600株 | +318.18% |
2018/01/05 | 日証協 | 52,600株 | -6.9% | 3,500株 | -79.29% | 165,358株 | +0.61% | 1,100株 | -96.11% |
2017/12/29 | 日証協 | 56,500株 | +11.22% | 16,900株 | +196.49% | 164,357株 | +19.14% | 28,310株 | +1186.82% |
2017/12/22 | 日証協 | 50,800株 | -0.2% | 5,700株 | -47.22% | 137,953株 | -2.2% | 2,200株 | -33.73% |
2017/12/15 | 日証協 | 50,900株 | -6.43% | 10,800株 | -25% | 141,058株 | -0.55% | 3,320株 | +10.67% |
2017/12/08 | 日証協 | 54,400株 | -14.06% | 14,400株 | +171.7% | 141,838株 | -4.12% | 3,000株 | -50% |
2017/12/01 | 日証協 | 63,300株 | -3.65% | 5,300株 | +278.57% | 147,938株 | +0.75% | 6,000株 | +1400% |
2017/11/24 | 日証協 | 65,700株 | -1.5% | 1,400株 | -22.22% | 146,838株 | -2.39% | 400株 | -84.62% |
2017/11/17 | 日証協 | 66,700株 | +1.52% | 1,800株 | +500% | 150,438株 | +0.4% | 2,600株 | +8.33% |
2017/11/10 | 日証協 | 65,700株 | +0.46% | 300株 | -93.62% | 149,838株 | +0.2% | 2,400株 | +33.33% |
2017/11/02 | 日証協 | 65,400株 | +0.31% | 4,700株 | -62.4% | 149,539株 | +1.01% | 1,800株 | +198.51% |
2017/10/27 | 日証協 | 65,200株 | +0.93% | 12,500株 | +303.23% | 148,039株 | -0.33% | 603株 | +50.75% |
2017/10/20 | 日証協 | 64,600株 | +0.62% | 3,100株 | +1450% | 148,536株 | -1.33% | 400株 | -69.23% |
2017/10/13 | 日証協 | 64,200株 | -0.31% | 200株 | -50% | 150,536株 | +0.2% | 1,300株 | -91.77% |
2017/10/06 | 日証協 | 64,400株 | -29% | 400株 | -99.29% | 150,236株 | +86.16% | 15,800株 | -90.25% |
2017/09/29 | 日証協 | 90,700株 | +118.55% | 56,100株 | +6133.33% | 80,702株 | -47.75% | 162,000株 | +9999.99% |
2017/09/22 | 日証協 | 41,500株 | +0.97% | 900株 | -95.57% | 154,439株 | -4.51% | 1,300株 | -96.08% |
※株式分割は考慮していませんのでご注意ください。